| Year |
Citation |
Score |
| 2019 |
Zhou T, Kong XL, Hider RC. Synthesis and iron chelating properties of hydroxypyridinone and hydroxypyranone hexadentate ligands. Dalton Transactions (Cambridge, England : 2003). PMID 30793715 DOI: 10.1039/C8Dt05014G |
0.67 |
|
| 2016 |
Xie YY, Lu Z, Kong XL, Zhou T, Bansal S, Hider R. Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone. European Journal of Medicinal Chemistry. 115: 132-140. PMID 27014847 DOI: 10.1016/J.Ejmech.2016.03.014 |
0.722 |
|
| 2016 |
Li J, Olaleye ED, Kong X, Zhou T, Ma Y, Jurach J, Al Rugaie O, Hider RC, Zhang G, Alsam S, Abbate V. Macromolecular iron-chelators via RAFT-polymerization for the inhibition of methicillin-resistant Staphylococcus aureus growth Polymer (United Kingdom). 87: 64-72. DOI: 10.1016/J.Polymer.2016.01.073 |
0.751 |
|
| 2015 |
Zhou YJ, Liu MS, Osamah AR, Kong XL, Alsam S, Battah S, Xie YY, Hider RC, Zhou T. Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains. European Journal of Medicinal Chemistry. 94: 8-21. PMID 25747496 DOI: 10.1016/J.Ejmech.2015.02.050 |
0.606 |
|
| 2014 |
Zhang MX, Zhu CF, Zhou YJ, Kong XL, Hider RC, Zhou T. Design, synthesis, and antimicrobial evaluation of hexadentate hydroxypyridinones with high iron(III) affinity. Chemical Biology & Drug Design. 84: 659-68. PMID 24890019 DOI: 10.1111/Cbdd.12358 |
0.673 |
|
| 2013 |
Arezes J, Costa M, Vieira I, Dias V, Kong XL, Fernandes R, Vos M, Carlsson A, Rikers Y, Porto G, Rangel M, Hider RC, Pinto JP. Non-transferrin-bound iron (NTBI) uptake by T lymphocytes: evidence for the selective acquisition of oligomeric ferric citrate species. Plos One. 8: e79870. PMID 24278199 DOI: 10.1371/Journal.Pone.0079870 |
0.625 |
|
| 2013 |
Li DF, Hu PP, Liu MS, Kong XL, Zhang JC, Hider RC, Zhou T. Design and synthesis of hydroxypyridinone-L-phenylalanine conjugates as potential tyrosinase inhibitors. Journal of Agricultural and Food Chemistry. 61: 6597-603. PMID 23802151 DOI: 10.1021/Jf401585F |
0.511 |
|
| 2013 |
Zhu CF, Qiu DH, Kong XL, Hider RC, Zhou T. Synthesis and in-vitro antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol. The Journal of Pharmacy and Pharmacology. 65: 512-20. PMID 23488779 DOI: 10.1111/Jphp.12013 |
0.668 |
|
| 2012 |
Chen YL, Barlow DJ, Kong XL, Ma YM, Hider RC. Prediction of 3-hydroxypyridin-4-one (HPO) log K1 values for Fe(III). Dalton Transactions (Cambridge, England : 2003). 41: 10784-91. PMID 22854534 DOI: 10.1039/C2Dt31254A |
0.707 |
|
| 2012 |
Chen YL, Barlow DJ, Kong XL, Ma YM, Hider RC. Prediction of 3-hydroxypyridin-4-one (HPO) hydroxyl pKa values. Dalton Transactions (Cambridge, England : 2003). 41: 6549-57. PMID 22395734 DOI: 10.1039/C2Dt12396G |
0.689 |
|
| 2012 |
Xie Y, Liu M, Hu P, Kong X, Qiu D, Xu J, Hider RC, Zhou T. Synthesis, physico-chemical properties, and antimicrobial evaluation of a new series of iron(III) hexadentate chelators Medicinal Chemistry Research. 22: 2351-2359. DOI: 10.1007/S00044-012-0229-1 |
0.683 |
|
| 2011 |
Xu B, Kong XL, Zhou T, Qiu DH, Chen YL, Liu MS, Yang RH, Hider RC. Synthesis, iron(III)-binding affinity and in vitro evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents. Bioorganic & Medicinal Chemistry Letters. 21: 6376-80. PMID 21937227 DOI: 10.1016/J.Bmcl.2011.08.097 |
0.752 |
|
| 2011 |
Hider RC, Kong XL. Glutathione: a key component of the cytoplasmic labile iron pool. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 24: 1179-87. PMID 21769609 DOI: 10.1007/S10534-011-9476-8 |
0.627 |
|
| 2011 |
Staff K, Brown MB, Chilcott RP, Hider RC, Jones SA, Kong XL. Ga(III) complexes-The effect of metal coordination on potential systemic absorption after topical exposure Toxicology Letters. 202: 155-160. PMID 21315140 DOI: 10.1016/J.Toxlet.2011.01.017 |
0.387 |
|
| 2011 |
Gaeta A, Molina-Holgado F, Kong XL, Salvage S, Fakih S, Francis PT, Williams RJ, Hider RC. Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease. Bioorganic & Medicinal Chemistry. 19: 1285-97. PMID 21236688 DOI: 10.1016/J.Bmc.2010.12.007 |
0.605 |
|
| 2010 |
Piyamongkol S, Ma YM, Kong XL, Liu ZD, Aytemir MD, van der Helm D, Hider RC. Amido-3-hydroxypyridin-4-ones as iron(III) ligands. Chemistry (Weinheim An Der Bergstrasse, Germany). 16: 6374-81. PMID 20397153 DOI: 10.1002/Chem.200902455 |
0.691 |
|
| 2009 |
Silva AM, Kong X, Parkin MC, Cammack R, Hider RC. Iron(III) citrate speciation in aqueous solution. Dalton Transactions (Cambridge, England : 2003). 8616-25. PMID 19809738 DOI: 10.1039/B910970F |
0.63 |
|
| 2009 |
Silva AM, Kong X, Hider RC. Determination of the pKa value of the hydroxyl group in the alpha-hydroxycarboxylates citrate, malate and lactate by 13C NMR: implications for metal coordination in biological systems. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 22: 771-8. PMID 19288211 DOI: 10.1007/S10534-009-9224-5 |
0.475 |
|
| 2008 |
Zhou T, Kong XL, Liu ZD, Liu DY, Hider RC. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers. Biomacromolecules. 9: 1372-80. PMID 18373358 DOI: 10.1021/Bm701122U |
0.758 |
|
| 2006 |
Zhou T, Neubert H, Liu DY, Liu ZD, Ma YM, Kong XL, Luo W, Mark S, Hider RC. Iron binding dendrimers: a novel approach for the treatment of haemochromatosis. Journal of Medicinal Chemistry. 49: 4171-82. PMID 16821777 DOI: 10.1021/Jm0600949 |
0.746 |
|
| 2005 |
Zhou T, Liu ZD, Neubert H, Kong XL, Ma YM, Hider RC. High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization. Bioorganic & Medicinal Chemistry Letters. 15: 5007-11. PMID 16153843 DOI: 10.1016/J.Bmcl.2005.08.008 |
0.731 |
|
| Show low-probability matches. |